Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid detected in multiple wild and specialised tea germplasms (Camellia sinensis) from South China, including Kucha. However, the molecular mechanisms governing its biosynthesis remain poorly understood. Here, we identify CsTcS2 as a novel theacrine synthase in tea plant. Functional assays involving heterologous expression in Nicotiana benthamiana, antisense oligonucleotide-mediated gene silencing, transient overexpression in tea plants and co-expression with caffeine dehydrogenase (CsCDH) confirm its catalytic role in converting caffeine to theacrine. Transcription factors CsTINY and CsWRKY33 directly bind the CsTcS2 promoter and activate its transcription, as demonstrated by yeast one-hybrid, dual-luciferase reporter and electrophoretic mobility shift assays. Further molecular docking, yeast two-hybrid, bimolecular fluorescence complementation, luciferase complementation, co-immunoprecipitation and antisense inhibition experiments reveal a synergistic interaction between CsTINY and CsWRKY33 that regulates CsTcS2 expression and thus controls theacrine biosynthesis. Together, our findings unravel the transcriptional regulatory network underlying theacrine biosynthesis and provide a molecular foundation for breeding tea cultivars with elevated theacrine levels for health-promoting applications.
Wu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: